Event Details

Joseph Schlessinger is the William H. Prusoff Professor and Chairman of the department of pharmacology at Yale School of Medicine. He is also the founding director of the new Cancer Biology Institute at Yale West Campus and chief scientist of Yale Cancer Center. From 1990 to 2001 he was the Helen and Milton A. Kimmelman Professor and Chairman of the department of pharmacology at New York University Medical Center. He was also the director of the Skirball Institute of NYU from 1998 until 2001. In 1991 he co-founded Sugen, Inc., in 2001 he co-founded Plexxikon, Inc., and in 2008 he founded Kolltan. From 1980 to 1991, Dr. Schlessinger was the Ruth and Leonard Simon Professor in Cancer Research in the department of chemical immunology at the Weizmann Institute of Science in Rehovot, Israel. Dr. Schlessinger was research director at Rorer Biotechnology, Inc., in Pennsylvania from 1988 to 1990. He has also held positions at Meloy Laboratories, Inc., in Rockville, Maryland, from 1985 to 1988.

Dr. Schlessinger has authored or co-authored more than 480 scientific articles and papers focusing on signal transduction, growth control mechanisms, receptor structure functions, and biophysics of proteins. He is a member of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences, a member of the Institute of Medicine of the National Academies, a member of the European Molecular Biology Organization (EMBO), and a foreign member of the Russian Academy of Sciences. He is on the editorial boards of Cell, Molecular Cell, EMBO J., The Journal of Cell Biology, and many other journals.

Dr. Schlessinger's academic honors include the Ciba-Drew Award, the Antoine Lacassagne Prize, the Distinguished Service Award from Miami Nature Biotechnology, the Taylor Prize, the Dan David Prize, and the Pezcoller Foundation-AACR International Award for Cancer, among other prizes. He presented the Randall Lecture at the University of Pennsylvania, the Sigma-Tau Lecture in Rome, the Burroughs Wellcome Lecture at Indiana University, the Juan March Lecture in Madrid, Spain, the Bayer Lecture at the University of California, Berkeley, the Sixteenth Annual Kenneth F. Naidorf Memorial Lecture at Columbia University, the Severo Ochoa Lecture in Madrid, Spain, the First Alton Meister Memorial Lecture at Weill Medical College of Cornell University, the Fritz Lipmann Lecture at the German Society for Biochemistry and Molecular Biology, the Karl Beyer Lectures at the University of Wisconsin at Madison, the Asher Rothstein Lecture in Toronto, Canada, the 33rd Annual Calbiochem-UCSD Lectureship Series, the 13th John F. Enders Lecture at Harvard Medical School, the 41st Annual Mager Lecture at Hebrew University, the Keith Porter Lecture at the ASCB Annual Meeting in San Diego, the Helen-Coley-Nauts Lecture at Moscow State University, and the EF Racker Lecture in Biology and Medicine at Cornell University, as well as numerous other named lectures.

Dr. Schlessinger received his bachelor's degree, magna cum laude, in chemistry and physics and his master's degree, magna cum laude, in chemistry from the Hebrew University of Jerusalem. He received his Ph.D. in biophysics from the department of chemical physics at the Weizmann Institute in Rehovot, Israel.

Type	Friday Lecture Series
Title	Cell Signaling by Receptor Tyrosine Kinases: From Basic Principles to Cancer Therapy
Subtitle	The Cancer Biology Lecture
Date	Friday, May 13, 2016
Time	3:45 p.m. - 5:00 p.m. (Refreshments, 3:15 p.m. - 3:45 p.m., Abby Reception Hall)
Location	Caspary Auditorium
Speaker(s)	Joseph Schlessinger, Ph.D., William H. Prusoff Professor and Chair, department of pharmacology, Yale School of Medicine
Speaker Bio	Joseph Schlessinger is the William H. Prusoff Professor and Chairman of the department of pharmacology at Yale School of Medicine. He is also the founding director of the new Cancer Biology Institute at Yale West Campus and chief scientist of Yale Cancer Center. From 1990 to 2001 he was the Helen and Milton A. Kimmelman Professor and Chairman of the department of pharmacology at New York University Medical Center. He was also the director of the Skirball Institute of NYU from 1998 until 2001. In 1991 he co-founded Sugen, Inc., in 2001 he co-founded Plexxikon, Inc., and in 2008 he founded Kolltan. From 1980 to 1991, Dr. Schlessinger was the Ruth and Leonard Simon Professor in Cancer Research in the department of chemical immunology at the Weizmann Institute of Science in Rehovot, Israel. Dr. Schlessinger was research director at Rorer Biotechnology, Inc., in Pennsylvania from 1988 to 1990. He has also held positions at Meloy Laboratories, Inc., in Rockville, Maryland, from 1985 to 1988. Dr. Schlessinger has authored or co-authored more than 480 scientific articles and papers focusing on signal transduction, growth control mechanisms, receptor structure functions, and biophysics of proteins. He is a member of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences, a member of the Institute of Medicine of the National Academies, a member of the European Molecular Biology Organization (EMBO), and a foreign member of the Russian Academy of Sciences. He is on the editorial boards of Cell, Molecular Cell, EMBO J., The Journal of Cell Biology, and many other journals. Dr. Schlessinger's academic honors include the Ciba-Drew Award, the Antoine Lacassagne Prize, the Distinguished Service Award from Miami Nature Biotechnology, the Taylor Prize, the Dan David Prize, and the Pezcoller Foundation-AACR International Award for Cancer, among other prizes. He presented the Randall Lecture at the University of Pennsylvania, the Sigma-Tau Lecture in Rome, the Burroughs Wellcome Lecture at Indiana University, the Juan March Lecture in Madrid, Spain, the Bayer Lecture at the University of California, Berkeley, the Sixteenth Annual Kenneth F. Naidorf Memorial Lecture at Columbia University, the Severo Ochoa Lecture in Madrid, Spain, the First Alton Meister Memorial Lecture at Weill Medical College of Cornell University, the Fritz Lipmann Lecture at the German Society for Biochemistry and Molecular Biology, the Karl Beyer Lectures at the University of Wisconsin at Madison, the Asher Rothstein Lecture in Toronto, Canada, the 33rd Annual Calbiochem-UCSD Lectureship Series, the 13th John F. Enders Lecture at Harvard Medical School, the 41st Annual Mager Lecture at Hebrew University, the Keith Porter Lecture at the ASCB Annual Meeting in San Diego, the Helen-Coley-Nauts Lecture at Moscow State University, and the EF Racker Lecture in Biology and Medicine at Cornell University, as well as numerous other named lectures. Dr. Schlessinger received his bachelor's degree, magna cum laude, in chemistry and physics and his master's degree, magna cum laude, in chemistry from the Hebrew University of Jerusalem. He received his Ph.D. in biophysics from the department of chemical physics at the Weizmann Institute in Rehovot, Israel.
Open To	Public
Host	James Darnell, Jr., M.D.
Phone	212-327-7714
Readings	http://librarynews.rockefeller.edu/?p=4093